J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 78 (1997), 147-152
© 1997 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibuki, K.
Right arrow Articles by Shida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibuki, K.
Right arrow Articles by Shida, H.
Agricola
Right arrow Articles by Ibuki, K.
Right arrow Articles by Shida, H.

Journal of General Virology, Vol 78, 147-152, Copyright © 1997 by Society for General Microbiology


ARTICLES

Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene

K Ibuki, SI Funahashi, H Yamamoto, M Nakamura, T Igarashi, T Miura, E Ido, M Hayami and H Shida
Institute for Virus Research, Kyoto University, Japan.

To develop effective vaccines against infection with human T cell leukaemia virus type I (HTLV-I), we constructed a recombinant vaccinia virus (WR-SFB5env) synthesizing the HTLV-I envelope (Env) gp46 protein under the control of a strong promoter, termed the ATI hybrid promoter. WR-SFB5env expressed a large quantity of gp46. In cynomolgus monkeys (Macaca fascicularis) immunized with WR-SFB5env, anti-HTLV-I Env antibody, including neutralizing antibody, was induced and remained at a high level until 136 weeks (2-6 years) post-infection (p.i.). These immunized monkeys had HTLV-I Env-specific cytotoxic T lymphocyte activity. At 136 weeks p.i., the immunized monkeys were challenged with an HTLV-I-producing cynomolgus T lymphocyte cell line. Neither HTLV-I antigen nor HTLV-I proviruses were detected in peripheral blood mononuclear cells, lymph nodes or spleens of the WR-SFB5env-immunized monkeys, in contrast to non-immunized control monkeys. These results indicate that a single immunization with WR-SFB5env induced prolonged humoral and cellular immune responses to HTLV-I and protected the monkeys against virus challenge.


This article has been cited by other articles:


Home page
J. Virol.Home page
A. Mirsaliotis, K. Nurkiyanova, D. Lamb, J. M. Woof, and D. W. Brighty
Conformation-Specific Antibodies Targeting the Trimer-of-Hairpins Motif of the Human T-Cell Leukemia Virus Type 1 Transmembrane Glycoprotein Recognize the Viral Envelope but Fail To Neutralize Viral Entry
J. Virol., June 1, 2007; 81(11): 6019 - 6031.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Kazanji, J.-M. Heraud, F. Merien, C. Pique, G. de The, A. Gessain, and S. Jacobson
Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1331 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Hakata, M. Yamada, and H. Shida
Rat CRM1 Is Responsible for the Poor Activity of Human T-Cell Leukemia Virus Type 1 Rex Protein in Rat Cells
J. Virol., December 1, 2001; 75(23): 11515 - 11525.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Kazanji, J. Tartaglia, G. Franchini, B. de Thoisy, A. Talarmin, H. Contamin, A. Gessain, and G. de The
Immunogenicity and Protective Efficacy of Recombinant Human T-Cell Leukemia/Lymphoma Virus Type 1 NYVAC and Naked DNA Vaccine Candidates in Squirrel Monkeys (Saimiri sciureus)
J. Virol., July 1, 2001; 75(13): 5939 - 5948.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Mortreux, M. Kazanji, A.-S. Gabet, B. de Thoisy, and E. Wattel
Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus)
J. Virol., January 15, 2001; 75(2): 1083 - 1089.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Kazanji, A. Ureta-Vidal, S. Ozden, F. Tangy, B. de Thoisy, L. Fiette, A. Talarmin, A. Gessain, and G. de Thé
Lymphoid Organs as a Major Reservoir for Human T-Cell Leukemia Virus Type 1 in Experimentally Infected Squirrel Monkeys (Saimiri sciureus): Provirus Expression, Persistence, and Humoral and Cellular Immune Responses
J. Virol., May 15, 2000; 74(10): 4860 - 4867.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.